<DOC>
	<DOCNO>NCT00974779</DOCNO>
	<brief_summary>The purpose study test whether dialyzer high usual permeability protein eliminate proinflammatory protein blood patient regular maintenance hemodialysis chronically elevated level inflammation marker C-reactive protein ( CRP ) blood .</brief_summary>
	<brief_title>High-cutoff Hemodialyzer Reduce Chronic Inflammation Hemodialysis Patients</brief_title>
	<detailed_description>Patients ESRD chronic hemodialysis patient frequently elevate marker inflammation ( e.g . serum CRP value ) . Hemodialysis may clear blood low molecular weight toxin retention product creatinine , potassium , urea . The dialyzer clearance middle high molecular weight substance cytokine cytokine receptor low . Nearly 50 % chronic dialysis patient persistent subclinical inflammation strongly associate cardiovascular disease mortality . The study test hypothesis removal protein weight range 10.000-30.000 D via permeable dialyzer membrane reduces chronic inflammation patient .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>regular hemodialysis least 3 month treatment thrice weekly highflux hemodialyzer least 4 week age &gt; 18 year &lt; 80 year least one CRP value &gt; 5mg/L within 8 week inclusion able understand consent study write informed consent consent clinically apparent acute infection CRP &gt; 50 mg/L serum albumin &lt; 3,5 mg/L central venous line dialysis access immunosuppressive medication pregnancy lactation inclusion interventional trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>kidney failure chronic</keyword>
	<keyword>renal dialysis</keyword>
	<keyword>inflammation</keyword>
	<keyword>monocyte</keyword>
	<keyword>end stage renal disease regular thrice weekly hemodialysis</keyword>
</DOC>